Sorafenib Withdrawn Phase 1 Trials for Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)

IndicationsStatusPurposePhase
WithdrawnNot Available1
clinicaltrials.gov IdentifierTitleDrugs
NCT00627835Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)